Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Finkelstein

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
Plos One|January 30, 2014
Increased Ndfip1 in the substantia nigra of Parkinsonian brains is associated with elevated iron levelsJason Howitt, Amanda M Gysbers, Scott Ayton, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 29, 2022
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of ParkinsonismLeah C Beauchamp, Xiang M Liu, Laura J Vella, et al.
Molecular and Biochemical Parasitology|October 27, 2004
Merozoite surface proteins 4 and 5 of Plasmodium knowlesi have differing cellular localisation and association with lipid raftsCasilda G Black, Lina Wang, Agnieszka E Topolska, et al.
NPJ Parkinson'S Disease|June 27, 2017
Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's diseaseDominic J Hare, Bárbara Rita Cardoso, Erika P Raven, et al.
Annals of Neurology|February 21, 2013
Ceruloplasmin dysfunction and therapeutic potential for Parkinson diseaseScott Ayton, Peng Lei, James A Duce, et al.
ACS Chemical Neuroscience|December 30, 2015
Effects of Neonatal Iron Feeding and Chronic Clioquinol Administration on the Parkinsonian Human A53T Transgenic MouseJessica L Billings, Dominic J Hare, Milawaty Nurjono, et al.
Journal of Neurochemistry|July 8, 2005
Chronic corticotropin-releasing factor type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawn-Hooded ratsA J Lawrence, C L Parish, F Chen, et al.
Journal of Neurochemistry|July 23, 2003
Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpcD Stanic, C L Parish, W M Zhu, et al.
Journal of Parkinson'S Disease|November 8, 2021
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System AtrophyDavid I Finkelstein, Jay J Shukla, Robert A Cherny, et al.
Biomaterials|January 11, 2014
Nanofibrous scaffolds releasing a small molecule BDNF-mimetic for the re-direction of endogenous neuroblast migration in the brainDeniece Fon, Kun Zhou, Francesca Ercole, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Plos One|January 30, 2014
Increased Ndfip1 in the substantia nigra of Parkinsonian brains is associated with elevated iron levelsJason Howitt, Amanda M Gysbers, Scott Ayton, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 29, 2022
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of ParkinsonismLeah C Beauchamp, Xiang M Liu, Laura J Vella, et al.
Molecular and Biochemical Parasitology|October 27, 2004
Merozoite surface proteins 4 and 5 of Plasmodium knowlesi have differing cellular localisation and association with lipid raftsCasilda G Black, Lina Wang, Agnieszka E Topolska, et al.
NPJ Parkinson'S Disease|June 27, 2017
Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's diseaseDominic J Hare, Bárbara Rita Cardoso, Erika P Raven, et al.
Annals of Neurology|February 21, 2013
Ceruloplasmin dysfunction and therapeutic potential for Parkinson diseaseScott Ayton, Peng Lei, James A Duce, et al.
ACS Chemical Neuroscience|December 30, 2015
Effects of Neonatal Iron Feeding and Chronic Clioquinol Administration on the Parkinsonian Human A53T Transgenic MouseJessica L Billings, Dominic J Hare, Milawaty Nurjono, et al.
Journal of Neurochemistry|July 8, 2005
Chronic corticotropin-releasing factor type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawn-Hooded ratsA J Lawrence, C L Parish, F Chen, et al.
Journal of Neurochemistry|July 23, 2003
Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpcD Stanic, C L Parish, W M Zhu, et al.
Journal of Parkinson'S Disease|November 8, 2021
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System AtrophyDavid I Finkelstein, Jay J Shukla, Robert A Cherny, et al.
Biomaterials|January 11, 2014
Nanofibrous scaffolds releasing a small molecule BDNF-mimetic for the re-direction of endogenous neuroblast migration in the brainDeniece Fon, Kun Zhou, Francesca Ercole, et al.
Pageof 25